For instance, one can easily envision the increase in quality of life in patients with familial adenomatous polyposis or somatic BRCA1 and 2 mutations where localized treatment leads to increased p16Ink4a activity, as seen in the naked mole rat, and thus prevents tumour formation. This evidence concerns the gene BRCA1 and Familial adenomatous polyposis.